Comparative efficiency of leucine-rich alpha-2 glycoprotein and fecal calprotectin to assess endoscopic activity in Crohn&apos;s disease: a prospective observational study

Inflammatory Bowel Disease

Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study

Clin Gastroenterol Hepatol

Louis E, Sebastian S, Siegmund B, Bossuyt P, Danese S, de Boer N, Loftus EV, Moum B, Peyrin-Biroulet L, Schreiber S, Zhou J, Angellotti E, Adsul S, Jones S, Siegel CA

doi: 10.1016/j.cgh.2025.10.006

Inflammatory Bowel Disease

Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study

Clin Gastroenterol Hepatol

Wewer MD, Lophaven S, Lakatos PL, Gonczi L, Salupere R, Linda Kievit HA, Nielsen KR, Midjord J, Domislovic V, Krznarić Ž, Pedersen N, Kjeldsen J, Halfvarson J, Sebastian S, Goldis A, Arebi N, Oksanen P, Neumann A, Andersen V, Katsanos KH, Koukoudis A, Turcan S, Ellul P, Kupcinskas J, Kiudelis G, Fumery M, Kaimakliotis IP, D'Inca R, Lombardini S, Hernandez V, Fernandez A, Langholz E, Munkholm P, Burisch J, Epi-IBD-group.

doi: 10.1016/j.cgh.2025.10.022

Inflammatory Bowel Disease

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg

J Crohns Colitis

De Greef E, Turner D, Kierkuś J, Korczowski B, Meglicka M, Cohen SA, Hyams JS, Griffiths AM, Rosh JR, Strauss R, Van Limbergen E, Adedokun OJ, Kim L, Volger S, UNITI Jr study Group

doi: 10.1093/ecco-jcc/jjag011

Inflammatory Bowel Disease

Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study

J Crohns Colitis

Peyrin-Biroulet L, Atreya R, Danese S, Lindsay JO, Chapman JC, Anschutz T, Huang X, Zambrano J, van Haaren S, Joshi N, Duan WR, Cross RK

doi: 10.1093/ecco-jcc/jjaf213

Inflammatory Bowel Disease

Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial

Inflamm Bowel Dis

Afzali A, Danese S, Panaccione R, Rubin DT, Sands BE, Reinisch W, Panés J, Van Rampelbergh R, Terry NA, Salese L, Vetter ML, Yee J, Corbett C, van Duijnhoven W, Hisamatsu T, Andrews JM, D'Haens GR, GALAXI 1 investigators

doi: 10.1093/ibd/izag055

Inflammatory Bowel Disease

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

United European Gastroenterol J

Mañosa M, Calafat M, Ricart E, Nos P, Iglesias E, Riestra S, Mesonero F, Calvo M, Guardiola J, Hernández V, Rivero M, Carpio D, Mínguez M, Alba C, Martín-Arranz MD, Vela M, Gomollón F, García-López S, Casbas AG, Calvet X, González-Muñoza C, Barrio J, Gisbert JP, Sicilia B, Pérez-Calle JL, Bujanda L, Esteve M, Ramos L, Varela P, Sierra M, Merino O, Bermejo F, Acosta MB, Perez AR, Márquez-Mosquera L, García-Bosch O, Rodríguez-Lago I, Lorente Poyatos RH, García Sepulcre MF, Maroto N, Vega P, Monfort D, San Martín LZ, Busquets D, Martinez-Montiel P, Riera J, Alcain G, Llaó J, Marin N, Marin-Jimenez I, Sesé E, Van Domselaar M, Huguet JM, Ginard D, Bas-Cutrina F, Ber Y, Roncero O, Lucendo AJ, López-García A, Menacho M, Almela P, Ponferrada Á, Coronel AF, Maestro S, de Jesús Martínez-Pérez T, Vilafranca CM, Argüelles F, Legido J, Gilabert P, Charro M, Trapero AM, Fernández H, Frago S, Villalba LH, Muñoz E, Domènech E, ENEIDA registry of GETECCU

doi: 10.1002/ueg2.70150

Inflammatory Bowel Disease

Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey

J Crohns Colitis

Moreira PL, Dignass A, Estevinho MM, Santiago M, Reinisch W, Sands BE, D'Haens G, Mantzaris GJ, Danese S, Peyrin-Biroulet L, Dotan I, Jairath V, Magro F, International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)

doi: 10.1093/ecco-jcc/jjaf178

Inflammatory Bowel Disease

Use of Intestinal Ultrasound in a Tight monitoring approach in Crohn's disease: a multicentre prospective study

Clin Gastroenterol Hepatol

Palmela C, Revés J, Frias-Gomes C, Morão B, Neto C, Bargas A, Glória L, Cravo M, Manso M, Dias de Castro F, Gonçalves TC, Cotter J, Coelho R, Caldeira A, Torres J

doi: 10.1016/j.cgh.2026.03.042

Inflammatory Bowel Disease

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone

Inflamm Bowel Dis

Vuyyuru SK, Goodwin SW, Solitano V, Ramsewak D, Kassam Z, Townsend C, Gregor J, Beaton M, Crowley E, Alkhattabi M, Sey M, Jairath V

doi: 10.1093/ibd/izag114

Gastroenterology

Comparative efficiency of leucine-rich alpha-2 glycoprotein and fecal calprotectin to assess endoscopic activity in Crohn's disease: a prospective observational study

Related content

Long-term safety of vedolizumab in patients with ulcerative colitis/Crohn's disease: A prospective observational study

Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study

Ustekinumab therapy for moderately to severely active pediatric Crohn's disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg

Efficacy and Safety of Risankizumab in Patients with Moderately to Severely Active Crohn's Disease: Interim Results from the SEQUENCE Open-Label Extension Study

Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trial

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

Establishing a Multiple Outcome Set for Crohn's Disease in Real-World Evidence Studies: Results from a Delphi e-Survey

Use of Intestinal Ultrasound in a Tight monitoring approach in Crohn's disease: a multicentre prospective study

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone